This usually includes: Patients body mass index (BMI) confirms obesity or overweight status Medical history showing previous weight loss attempts through diet, exercise, or other medications Diagnosis of obesity-related conditions, such as OSA Evidence that the patient does not have contraindications like a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Providing thorough and accurate documentation speeds up the approval process, reducing delays in starting treatment
Additionally, Lilly saw no signs of liver-related safety issues
What is the Japan growth outlook in this report
Because of these effects, people on GLP-1 medications tend to eat less without extreme willpower, making it easier to maintain a calorie deficit
In addition to their effects on glycaemic control, some of these medications are indicated for weight management and are therefore gaining popularity
Side effects can include nausea, vomiting, low blood sugar, and kidney injury, so discuss safer access and alternatives with your doctor
